Suppr超能文献

能够有效使移植细胞在肝脏中再增殖的模型系统和实验条件。

Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells.

机构信息

Marion Bessin Liver Research Center, Department of Medicine and Division of Hepatology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Int J Biochem Cell Biol. 2011 Feb;43(2):198-213. doi: 10.1016/j.biocel.2010.01.013. Epub 2010 Jan 18.

Abstract

In recent years, there has been substantial progress in transplanting cells into the liver with the ultimate goal of restoring liver mass and function in both inherited and acquired liver diseases. The basis for considering that this might be feasible is that the liver is a highly regenerative organ. After massive liver injury or surgical removal of two-thirds or more of the liver tissue, the organ can restore its mass with completely normal morphologic structure and function. It has also been found under highly selective conditions that transplanted hepatocytes can fully repopulate the liver and cure a metabolic disorder or deficiency state. Fetal liver cells can also substantially repopulate the normal liver, and it is hoped in the future that effective repopulation will be achievable with cultured cells or cell lines, pluripotent stem cells from other somatic tissues, embryonic stem cells, or induced pluripotent stem cells, which can now be generated in vitro by a variety of methods. The purpose of this review is to present the major systems that have been used for liver repopulation, the variables involved in obtaining successful repopulation and what has been achieved in these various systems to date with different cell types.

摘要

近年来,在将细胞移植到肝脏中以恢复遗传和获得性肝脏疾病的肝质量和功能方面取得了实质性进展。考虑到这可能是可行的,其基础是肝脏是一个高度再生的器官。在大量肝损伤或手术切除三分之二或更多的肝组织后,该器官可以恢复其具有完全正常形态结构和功能的质量。在高度选择性条件下,也发现移植的肝细胞可以完全再填充肝脏并治愈代谢紊乱或缺乏状态。胎儿肝细胞也可以大量再填充正常肝脏,未来有望通过培养细胞或细胞系、来自其他体细胞的多能干细胞、胚胎干细胞或诱导多能干细胞来实现有效的再填充,这些细胞现在可以通过多种方法在体外生成。本综述的目的是介绍已用于肝脏再填充的主要系统、获得成功再填充所涉及的变量以及迄今为止使用不同细胞类型在这些不同系统中取得的成就。

相似文献

1
Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells.
Int J Biochem Cell Biol. 2011 Feb;43(2):198-213. doi: 10.1016/j.biocel.2010.01.013. Epub 2010 Jan 18.
2
Fetal liver cell transplantation as a potential alternative to whole liver transplantation?
J Gastroenterol. 2011 Aug;46(8):953-65. doi: 10.1007/s00535-011-0427-5. Epub 2011 Jun 24.
3
Hepatocyte transplantation: waiting for stem cells.
Curr Opin Organ Transplant. 2008 Dec;13(6):627-32. doi: 10.1097/MOT.0b013e328317a44f.
4
Hepatoblast-like progenitor cells derived from embryonic stem cells can repopulate livers of mice.
Gastroenterology. 2010 Dec;139(6):2158-2169.e8. doi: 10.1053/j.gastro.2010.08.042. Epub 2010 Aug 27.
5
Therapeutic potential of hepatocyte transplantation.
Semin Cell Dev Biol. 2002 Dec;13(6):439-46. doi: 10.1016/s1084952102001325.
7
Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?
Gut. 2009 Apr;58(4):594-603. doi: 10.1136/gut.2008.171116. Epub 2008 Dec 17.
8
Cell therapy for liver disease: From liver transplantation to cell factory.
J Hepatol. 2015 Apr;62(1 Suppl):S157-69. doi: 10.1016/j.jhep.2015.02.040.
9
Stem cells, cell transplantation and liver repopulation.
Biochim Biophys Acta. 2008 Feb;1782(2):61-74. doi: 10.1016/j.bbadis.2007.12.004. Epub 2007 Dec 23.
10
Murine embryonic stem cell-derived hepatocytes correct metabolic liver disease after serial liver repopulation.
Int J Biochem Cell Biol. 2012 Apr;44(4):648-58. doi: 10.1016/j.biocel.2012.01.002. Epub 2012 Jan 10.

引用本文的文献

1
Cell therapy in end-stage liver disease: replace and remodel.
Stem Cell Res Ther. 2023 May 25;14(1):141. doi: 10.1186/s13287-023-03370-z.
2
Sexual Dimorphism in Hepatocyte Xenograft Models.
Cell Transplant. 2021 Jan-Dec;30:9636897211006132. doi: 10.1177/09636897211006132.
6
Alcoholic liver disease: Utility of animal models.
World J Gastroenterol. 2018 Dec 7;24(45):5063-5075. doi: 10.3748/wjg.v24.i45.5063.
7
Donor-derived hepatocytes in human hematopoietic cell transplant recipients: evidence of fusion.
Virchows Arch. 2019 Mar;474(3):365-374. doi: 10.1007/s00428-018-2497-8. Epub 2018 Dec 12.
9
Insulin-like growth factor 2 is a key mitogen driving liver repopulation in mice.
Cell Death Dis. 2018 Jan 18;9(2):26. doi: 10.1038/s41419-017-0186-1.
10
Wilson's disease: Prospective developments towards new therapies.
World J Gastroenterol. 2017 Aug 14;23(30):5451-5456. doi: 10.3748/wjg.v23.i30.5451.

本文引用的文献

4
Dynamic signaling network for the specification of embryonic pancreas and liver progenitors.
Science. 2009 Jun 26;324(5935):1707-10. doi: 10.1126/science.1174497.
5
Generation of induced pluripotent stem cells using recombinant proteins.
Cell Stem Cell. 2009 May 8;4(5):381-4. doi: 10.1016/j.stem.2009.04.005. Epub 2009 Apr 23.
6
Foxl1 is a marker of bipotential hepatic progenitor cells in mice.
Hepatology. 2009 Mar;49(3):920-9. doi: 10.1002/hep.22705.
7
Origin of stem cells in organogenesis.
Science. 2008 Dec 5;322(5907):1498-501. doi: 10.1126/science.1162782.
8
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.
Gastroenterology. 2009 Mar;136(3):990-9. doi: 10.1053/j.gastro.2008.10.047. Epub 2008 Oct 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验